You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Sale Disclosure
Cline Christopher R. · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$1.3M
Cline Christopher R. Chief Financial Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
TVTX daily price context
Close on/before transaction
$62.51
Sep 15, 2026
First close after public filing
$62.76
Sep 18, 2026
30-day return after filing
-19.55%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,735 shares @ $62.61
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001943192-26-000006
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$3.5M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $121K |
| Travere Therapeutics, Inc. TVTX Current | Sale | Sep 15, 2026 | $1.3M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $348.8K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $1.7M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $26.12K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |